Bedaquiline is a drug used to treat tuberculosis (TB). It is a member of the diarylquinoline class of drugs, and is the first new TB drug to be approved by the US Food and Drug Administration (FDA) in over 40 years. It is used to treat multi-drug resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). Bedaquiline is administered as an oral tablet and is usually taken in combination with other TB drugs. Bedaquiline is part of the respiratory drug market, which includes drugs used to treat a variety of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The market is highly competitive, with many companies developing and marketing drugs to treat respiratory diseases. Some companies in the Bedaquiline market include Johnson & Johnson, Otsuka Pharmaceuticals, and Mylan. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
